Early research (Phase 1)Study completedNCT01462773
What this trial is testing
Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma
Who this might be right for
Melanoma
Ohio State University Comprehensive Cancer Center 16